BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 8734301)

  • 21. Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions.
    Kunst CB; Mezey E; Brownstein MJ; Patterson D
    Nat Genet; 1997 Jan; 15(1):91-4. PubMed ID: 8988176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial amyotrophic lateral sclerosis.
    Siddique T; Nijhawan D; Hentati A
    J Neural Transm Suppl; 1997; 49():219-33. PubMed ID: 9266431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superoxide dismutase-1 mutation-related neurotoxicity in familial amyotrophic lateral sclerosis.
    Shibata N; Hirano A; Yamamoto T; Kato Y; Kobayashi M
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Jun; 1(3):143-61. PubMed ID: 11464949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies.
    Gurney ME
    J Neurol Sci; 1997 Oct; 152 Suppl 1():S67-73. PubMed ID: 9419057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological treatment of ALS.
    Münch C; Ludolph AC
    Neurol Neurochir Pol; 2001; 35(1 Suppl):41-50. PubMed ID: 11732279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Familial amyotrophic lateral sclerosis and a mutation of Cu/Zn superoxide dismutase gene].
    Nakano R; Tsuji S
    No To Shinkei; 1995 Jun; 47(6):529-34. PubMed ID: 7605679
    [No Abstract]   [Full Text] [Related]  

  • 27. Genetics of amyotrophic lateral sclerosis.
    Siddique T; Deng HX
    Hum Mol Genet; 1996; 5 Spec No():1465-70. PubMed ID: 8875253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Superoxide dismutase-1 (SOD-1) gene mutation-dependent mechanisms of neural degeneration in amyotrophic lateral sclerosis].
    Iłzecka J
    Neurol Neurochir Pol; 2001; 35(3):461-9. PubMed ID: 11732268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Difficulties in distinguishing sporadic from familial amyotrophic lateral sclerosis.
    Orrell RW; Habgood J; Rudge P; Lane RJ; de Belleroche JS
    Ann Neurol; 1996 Jun; 39(6):810-2. PubMed ID: 8651656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatocyte growth factor therapy for amyotrophic lateral sclerosis].
    Aoki M
    Brain Nerve; 2012 Mar; 64(3):245-54. PubMed ID: 22402718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of chaperone activity is a shared property of several Cu,Zn-superoxide dismutase mutants that cause amyotrophic lateral sclerosis.
    Tummala H; Jung C; Tiwari A; Higgins CM; Hayward LJ; Xu Z
    J Biol Chem; 2005 May; 280(18):17725-31. PubMed ID: 15753080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenic mechanisms in sporadic amyotrophic lateral sclerosis.
    Eisen A; Krieger C
    Can J Neurol Sci; 1993 Nov; 20(4):286-96. PubMed ID: 8313244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.
    Gurney ME; Pu H; Chiu AY; Dal Canto MC; Polchow CY; Alexander DD; Caliendo J; Hentati A; Kwon YW; Deng HX
    Science; 1994 Jun; 264(5166):1772-5. PubMed ID: 8209258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis.
    Browne SE; Bowling AC; Baik MJ; Gurney M; Brown RH; Beal MF
    J Neurochem; 1998 Jul; 71(1):281-7. PubMed ID: 9648876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Familial amyotrophic lateral sclerosis with or without mutation of the Cu/Zn superoxide dismutase gene].
    Takahashi H
    No To Shinkei; 1995 Jun; 47(6):535-41. PubMed ID: 7605680
    [No Abstract]   [Full Text] [Related]  

  • 36. Canine degenerative myelopathy.
    Coates JR; Wininger FA
    Vet Clin North Am Small Anim Pract; 2010 Sep; 40(5):929-50. PubMed ID: 20732599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity.
    Siddique T; Figlewicz DA; Pericak-Vance MA; Haines JL; Rouleau G; Jeffers AJ; Sapp P; Hung WY; Bebout J; McKenna-Yasek D
    N Engl J Med; 1991 May; 324(20):1381-4. PubMed ID: 2020294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of neurodegeneration in amyotrophic lateral sclerosis.
    Cluskey S; Ramsden DB
    Mol Pathol; 2001 Dec; 54(6):386-92. PubMed ID: 11724913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis.
    Bowling AC; Barkowski EE; McKenna-Yasek D; Sapp P; Horvitz HR; Beal MF; Brown RH
    J Neurochem; 1995 May; 64(5):2366-9. PubMed ID: 7722523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis.
    Ripps ME; Huntley GW; Hof PR; Morrison JH; Gordon JW
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):689-93. PubMed ID: 7846037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.